乾性加齢黄斑変性の世界市場：動向、予測、競合分析（～2030年）

世界の乾性加齢黄斑変性の市場規模は、2024～2030年にかけてCAGR 7.1％で成長すると予測されています。この市場の主な促進要因は、高齢者人口の増加と加齢黄斑変性の罹患率の増加です。世界の乾性加齢黄斑変性市場は、病院・診療所、診断センター、学術・研究機関市場に機会があり、将来性が期待されます。

乾性加齢黄斑変性市場の洞察

Lucintelの予測では、高齢者人口の増加により、75歳以上が予測期間中に最大の成長を遂げる見込みです。

この市場の中では、病院に高度で包括的な治療設備が設置されていることから、病院・診療所が最大のセグメントであり続けると思われます。

北米は、政府のイニシアチブと財政的支援がこの地域の市場拡大をさらに後押ししているため、予測期間中に最も高い成長が見込まれています。

よくある質問

Q1.市場の成長予測は？

A1.世界の乾性加齢黄斑変性市場は、2024～2030年にかけてCAGR 7.1％で成長すると予測されています。

Q2.市場の成長に影響を与える主な促進要因は？

A2.この市場の主な促進要因は、高齢者人口の増加と加齢黄斑変性の罹患率の増加です。

Q3.市場の主要セグメントは？

A3.乾性加齢黄斑変性市場の将来性は、病院・診療所、診断センター、学術・研究機関市場において有望です。

Q4.市場の主要企業は？

A4.乾性加齢黄斑変性の主要企業は以下の通りです。

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Q5.今後、最大となる市場セグメントは？

A5.Lucintelは、高齢者人口の増加により、75歳以上が予測期間中に最大の成長を遂げると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は？

A6.北米は、政府のイニシアチブと財政支援がこの地域の市場拡大をさらに促進しているため、予測期間中に最も高い成長を示すと予想されます。

Q7.レポートのカスタマイズは可能？

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の乾性加齢黄斑変性市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の乾性加齢黄斑変性の市場動向（2018～2023年）と予測（2024～2030年）
• 世界の乾性加齢黄斑変性市場：年齢層別
  • 75歳以上
  • 60歳以上
  • 40歳以上
• 世界の乾性加齢黄斑変性市場：診断・治療別
  • 治療
  • 診断
• 世界の乾性加齢黄斑変性市場：投与経路別
  • 経口
  • 注射剤
• 世界の乾性加齢黄斑変性市場：最終用途産業別
  • 病院・診療所
  • 診断センター
  • 学術調査機関
  • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

• 世界の乾性加齢黄斑変性市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 年齢層別
  • 診断・治療別
  • 投与経路別
  • 最終用途産業別
  • 地域別
• 世界の乾性加齢黄斑変性市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の乾性加齢黄斑変性市場の能力拡大
  • 世界の乾性加齢黄斑変性市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Dry Age Related Macular Degeneration Trends and Forecast

The future of the global dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets. The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

A more than 150-page report is developed to help in your business decisions.

Dry Age Related Macular Degeneration by Segment

The study includes a forecast for the global dry age related macular degeneration by age group, diagnosis & treatment, route of administration, end use industry, and region.

Dry Age Related Macular Degeneration Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

• Above 75 Years
• Above 60 Years
• Above 40 Years

Dry Age Related Macular Degeneration Market by Diagnosis & Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Treatment
• Diagnosis

Dry Age Related Macular Degeneration Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Injectables

Dry Age Related Macular Degeneration Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others

Dry Age Related Macular Degeneration Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Dry Age Related Macular Degeneration Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dry age related macular degeneration companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dry age related macular degeneration companies profiled in this report include-

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Dry Age Related Macular Degeneration Market Insights

Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Within this market, hospitals & clinics will remain the largest segment due to the installation of advanced and comprehensive treatment facilities in hospitals.

North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Features of the Global Dry Age Related Macular Degeneration Market

Market Size Estimates: Dry age related macular degeneration market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dry age related macular degeneration market size by various segments, such as by age group, diagnosis & treatment, route of administration, end use industry, and region in terms of value ($B).

Regional Analysis: Dry age related macular degeneration market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different age group, diagnosis & treatment, route of administration, end use industry, and regions for the dry age related macular degeneration market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dry age related macular degeneration market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for dry age related macular degeneration market?

Answer: The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the dry age related macular degeneration market?

Answer: The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

Q3. What are the major segments for dry age related macular degeneration market?

Answer: The future of the dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets.

Q4. Who are the key dry age related macular degeneration market companies?

Answer: Some of the key dry age related macular degeneration companies are as follows.

• Santen Pharmaceuticals
• Allergan
• Bausch Health
• Alimera Science
• Phio Pharmaceuticals
• Ocumension Therapeutics
• Belite Bio
• Kubota Vision
• Iveric Bio
• Eyestem Research

Q5. Which dry age related macular degeneration market segment will be the largest in future?

Answer: Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Q6. In dry age related macular degeneration market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dry age related macular degeneration market by age group (above 75 years, above 60 years, and above 40 years), diagnosis & treatment (treatment and diagnosis), route of administration (oral and injectables), end use industry (hospitals & clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dry Age Related Macular Degeneration Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Dry Age Related Macular Degeneration Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Dry Age Related Macular Degeneration Market by Age Group
  • 3.3.1: Above 75 Years
  • 3.3.2: Above 60 Years
  • 3.3.3: Above 40 Years
• 3.4: Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
  • 3.4.1: Treatment
  • 3.4.2: Diagnosis
• 3.5: Global Dry Age Related Macular Degeneration Market by Route of Administration
  • 3.5.1: Oral
  • 3.5.2: Injectables
• 3.6: Global Dry Age Related Macular Degeneration Market by End Use Industry
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Diagnostic Centers
  • 3.6.3: Academic & Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Dry Age Related Macular Degeneration Market by Region
• 4.2: North American Dry Age Related Macular Degeneration Market
  • 4.2.2: North American Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
• 4.3: European Dry Age Related Macular Degeneration Market
  • 4.3.1: European Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
  • 4.3.2: European Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
• 4.4: APAC Dry Age Related Macular Degeneration Market
  • 4.4.1: APAC Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
  • 4.4.2: APAC Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
• 4.5: ROW Dry Age Related Macular Degeneration Market
  • 4.5.1: ROW Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
  • 4.5.2: ROW Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Age Group
  • 6.1.2: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
  • 6.1.3: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Route of Administration
  • 6.1.4: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Region
• 6.2: Emerging Trends in the Global Dry Age Related Macular Degeneration Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Dry Age Related Macular Degeneration Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dry Age Related Macular Degeneration Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Santen Pharmaceuticals
• 7.2: Allergan
• 7.3: Bausch Health
• 7.4: Alimera Science
• 7.5: Phio Pharmaceuticals
• 7.6: Ocumension Therapeutics
• 7.7: Belite Bio
• 7.8: Kubota Vision
• 7.9: Iveric Bio
• 7.10: Eyestem Research